Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vitiligo
|
249 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.800 | 1.000 | 2 | 2012 | 2016 | |||||
Inflammatory Bowel Diseases
|
605 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.710 | 1.000 | 2 | 2011 | 2015 | |||||
Psoriasis
|
705 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 3 | 2012 | 2016 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||
Ulcerative Colitis
|
827 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 2 | 2015 | 2016 | |||||
Ankylosing spondylitis
|
609 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Cholangitis, Sclerosing
|
276 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Crohn Disease
|
1147 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Eosinophil count procedure
|
1144 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Hypothyroidism
|
283 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Serum total cholesterol measurement
|
1243 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Addison's disease due to autoimmunity
|
18 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Autoimmune Primary Adrenal Insufficiency
|
18 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetes
|
710 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Diabetes Mellitus
|
824 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Hepatitis C
|
347 | 0.724 | 0.280 | 2 | 162254026 | regulatory region variant | A/G | snv | 0.46 | 0.010 | 1 | 2019 | 2019 |